ArticlePloS one2015

Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.

Julian P Halcox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.